[96a5a0]: / output / allTrials / identified / NCT00971191_identified.json

Download this file

257 lines (257 with data), 11.2 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
{
"info": {
"nct_id": "NCT00971191",
"official_title": "A Presurgical Study To Evaluate Molecular Changes That Occur In Human Non-Small Cell Lung Cancer Tissue After Short Term Exposure To PF-00299804",
"inclusion_criteria": "* Radiographs consistent with lung cancer for which resection is indicated upon histologic confirmation of non-small cell lung cancer.\n* Patient willing to take PF-00299804 for 5 to 11 days and provide blood and tissue specimens as required in the study.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Prior or concurrent systemic anticancer therapy for cancer (immunotherapy, hormonotherapy, biological therapy, or chemotherapy) less than one year from time of consent.\n* Prior or concurrent radiation therapy to tumor at site of planned resection.\n* Congestive heart failure (LVEF < 50%), uncontrolled hypertension, significant ventricular arrythmia.\n* Drugs that are highly dependent on CYP2D6 for metabolism, or are generally accepted to have a risk of causing Torsades de Pointes.\n* Prior or concurrent radiation therapy to tumor at site of planned resection.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Radiographs consistent with lung cancer for which resection is indicated upon histologic confirmation of non-small cell lung cancer.",
"criterions": [
{
"exact_snippets": "Radiographs consistent with lung cancer",
"criterion": "lung cancer",
"requirements": [
{
"requirement_type": "consistency",
"expected_value": "radiographs"
}
]
},
{
"exact_snippets": "resection is indicated",
"criterion": "resection",
"requirements": [
{
"requirement_type": "indication",
"expected_value": true
}
]
},
{
"exact_snippets": "histologic confirmation of non-small cell lung cancer",
"criterion": "non-small cell lung cancer",
"requirements": [
{
"requirement_type": "confirmation",
"expected_value": "histologic"
}
]
}
]
},
{
"line": "* Patient willing to take PF-00299804 for 5 to 11 days and provide blood and tissue specimens as required in the study.",
"criterions": [
{
"exact_snippets": "Patient willing to take PF-00299804",
"criterion": "willingness to take PF-00299804",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": true
}
]
},
{
"exact_snippets": "provide blood and tissue specimens",
"criterion": "provision of blood and tissue specimens",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Prior or concurrent systemic anticancer therapy for cancer (immunotherapy, hormonotherapy, biological therapy, or chemotherapy) less than one year from time of consent.",
"criterions": [
{
"exact_snippets": "Prior or concurrent systemic anticancer therapy for cancer (immunotherapy, hormonotherapy, biological therapy, or chemotherapy)",
"criterion": "systemic anticancer therapy",
"requirements": [
{
"requirement_type": "timing",
"expected_value": "prior or concurrent"
},
{
"requirement_type": "types",
"expected_value": [
"immunotherapy",
"hormonotherapy",
"biological therapy",
"chemotherapy"
]
}
]
},
{
"exact_snippets": "less than one year from time of consent",
"criterion": "time since last systemic anticancer therapy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": "<",
"value": 1,
"unit": "year"
}
}
]
}
]
},
{
"line": "* Prior or concurrent radiation therapy to tumor at site of planned resection.",
"criterions": [
{
"exact_snippets": "Prior or concurrent radiation therapy to tumor at site of planned resection.",
"criterion": "radiation therapy to tumor",
"requirements": [
{
"requirement_type": "timing",
"expected_value": [
"prior",
"concurrent"
]
},
{
"requirement_type": "location",
"expected_value": "site of planned resection"
}
]
}
]
},
{
"line": "* Congestive heart failure (LVEF < 50%), uncontrolled hypertension, significant ventricular arrythmia.",
"criterions": [
{
"exact_snippets": "Congestive heart failure (LVEF < 50%)",
"criterion": "congestive heart failure",
"requirements": [
{
"requirement_type": "LVEF",
"expected_value": {
"operator": "<",
"value": 50,
"unit": "%"
}
}
]
},
{
"exact_snippets": "uncontrolled hypertension",
"criterion": "hypertension",
"requirements": [
{
"requirement_type": "control",
"expected_value": "uncontrolled"
}
]
},
{
"exact_snippets": "significant ventricular arrythmia",
"criterion": "ventricular arrythmia",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "significant"
}
]
}
]
},
{
"line": "* Drugs that are highly dependent on CYP2D6 for metabolism, or are generally accepted to have a risk of causing Torsades de Pointes.",
"criterions": [
{
"exact_snippets": "Drugs that are highly dependent on CYP2D6 for metabolism",
"criterion": "CYP2D6 metabolism dependency",
"requirements": [
{
"requirement_type": "dependency",
"expected_value": "high"
}
]
},
{
"exact_snippets": "Drugs that ... have a risk of causing Torsades de Pointes",
"criterion": "risk of causing Torsades de Pointes",
"requirements": [
{
"requirement_type": "risk",
"expected_value": true
}
]
}
]
},
{
"line": "* Prior or concurrent radiation therapy to tumor at site of planned resection.",
"criterions": [
{
"exact_snippets": "Prior or concurrent radiation therapy to tumor at site of planned resection.",
"criterion": "radiation therapy to tumor",
"requirements": [
{
"requirement_type": "timing",
"expected_value": [
"prior",
"concurrent"
]
},
{
"requirement_type": "location",
"expected_value": "site of planned resection"
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}